We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Doximity (DOCS) Surpasses Market Returns: Some Facts Worth Knowing
Read MoreHide Full Article
Doximity (DOCS - Free Report) ended the recent trading session at $28.58, demonstrating a +2.33% change from the preceding day's closing price. The stock outperformed the S&P 500, which registered a daily gain of 0.66%. Meanwhile, the Dow experienced a rise of 0.18%, and the technology-dominated Nasdaq saw an increase of 1.05%.
Coming into today, shares of the medical social networking site had gained 6% in the past month. In that same time, the Medical sector lost 3.74%, while the S&P 500 gained 0.55%.
The investment community will be closely monitoring the performance of Doximity in its forthcoming earnings report. It is anticipated that the company will report an EPS of $0.34, marking a 24.44% fall compared to the same quarter of the previous year. Meanwhile, our latest consensus estimate is calling for revenue of $170.66 million, up 1.27% from the prior-year quarter.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $1.33 per share and a revenue of $675.74 million, indicating changes of -12.5% and +4.79%, respectively, from the former year.
It is also important to note the recent changes to analyst estimates for Doximity. Such recent modifications usually signify the changing landscape of near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate remained stagnant. Doximity is currently sporting a Zacks Rank of #3 (Hold).
Looking at valuation, Doximity is presently trading at a Forward P/E ratio of 20.93. This indicates a discount in contrast to its industry's Forward P/E of 31.16.
Meanwhile, DOCS's PEG ratio is currently 12.17. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. The average PEG ratio for the Medical Info Systems industry stood at 3.11 at the close of the market yesterday.
The Medical Info Systems industry is part of the Medical sector. With its current Zacks Industry Rank of 83, this industry ranks in the top 34% of all industries, numbering over 250.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
View the Zacks #1 Rank List
Image: Bigstock
Doximity (DOCS) Surpasses Market Returns: Some Facts Worth Knowing
Doximity (DOCS - Free Report) ended the recent trading session at $28.58, demonstrating a +2.33% change from the preceding day's closing price. The stock outperformed the S&P 500, which registered a daily gain of 0.66%. Meanwhile, the Dow experienced a rise of 0.18%, and the technology-dominated Nasdaq saw an increase of 1.05%.
Coming into today, shares of the medical social networking site had gained 6% in the past month. In that same time, the Medical sector lost 3.74%, while the S&P 500 gained 0.55%.
The investment community will be closely monitoring the performance of Doximity in its forthcoming earnings report. It is anticipated that the company will report an EPS of $0.34, marking a 24.44% fall compared to the same quarter of the previous year. Meanwhile, our latest consensus estimate is calling for revenue of $170.66 million, up 1.27% from the prior-year quarter.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $1.33 per share and a revenue of $675.74 million, indicating changes of -12.5% and +4.79%, respectively, from the former year.
It is also important to note the recent changes to analyst estimates for Doximity. Such recent modifications usually signify the changing landscape of near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate remained stagnant. Doximity is currently sporting a Zacks Rank of #3 (Hold).
Looking at valuation, Doximity is presently trading at a Forward P/E ratio of 20.93. This indicates a discount in contrast to its industry's Forward P/E of 31.16.
Meanwhile, DOCS's PEG ratio is currently 12.17. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. The average PEG ratio for the Medical Info Systems industry stood at 3.11 at the close of the market yesterday.
The Medical Info Systems industry is part of the Medical sector. With its current Zacks Industry Rank of 83, this industry ranks in the top 34% of all industries, numbering over 250.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.